SeaStar Medical Holding (ICU) Cash from Financing Activities (2021 - 2026)

SeaStar Medical Holding (ICU) has 6 years of Cash from Financing Activities data on file, last reported at $129000.0 in Q1 2026.

• Quarterly Cash from Financing Activities fell 97.9% year-over-year to $129000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.8 million (up 14.94% YoY) and the FY2025 annual result came in at $23.8 million, up 34.62% from the prior year.
• Cash from Financing Activities slipped to $129000.0 in Q1 2026, from $2.3 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $11.3 million in Q3 2025 to a low of -$1.0 million in Q2 2024.
• A 5-year average of $3.5 million and a median of $3.0 million in 2023 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities surged 1256.3% — and 2024, when it plunged 169.73%.
• Tracing ICU's Cash from Financing Activities over 5 years: stood at $5.3 million in 2022, then retreated by 13.43% to $4.6 million in 2023, then retreated by 3.44% to $4.4 million in 2024, then plunged by 47.83% to $2.3 million in 2025, then slumped by 94.42% to $129000.0 in 2026.
• The last three Cash from Financing Activities figures came in at $129000.0 (Q1 2026), $2.3 million (Q4 2025), and $11.3 million (Q3 2025), per Business Quant data.